Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Avidity Biosciences Announces Positive Topline Data from Myotonic Dystrophy Trial
Avidity Biosciences, a biopharmaceutical company committed to delivering a new class of RNA therapeutics called […]
Verana Health Announces the Qdata Parkinson's Disease Module at 2023 AAN Annual Meeting
Verana Health, a digital health company elevating quality in real-world data (RWD), has announced it’s […]
Jazz Pharmaceuticals to Present Advancements in Neuroscience at American Academy of Neurology Annual Meeting
Jazz Pharmaceuticals today announced that eleven abstracts from across its neuroscience portfolio and pipeline, including […]
New Roche Data at 2021 AAN Highlight Neuroscience Portfolio
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data for its approved and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more